Judith A. Reinsdorf
Known title: DirectorCIK: 0001305361
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 4, 2026
Morgan Stanley initiates Toll Brothers coverage with Overweight rating. Morgan Stanley began covering Toll Brothers with an Overweight rating and a $159 price target. The firm positioned the homebuilder favorably compared to Berkshire Hathaway's preferred peers. This analyst action adds to a broader group of initiations reported this week, providing fresh institutional perspective on the stock.
Transaction History
| NPO | ▲ Buy | Grant | 567 | $140K | 2/12/2026 | View on chart |
| TOL | ▲ Buy | Option Exercise | 1,295 | $0 | 1/19/2026 | View on chart |
| NPO | ▲ Buy | Grant | 685 | $125K | 2/13/2025 | View on chart |
| NPO | ▲ Buy | Grant | 803 | $125K | 2/15/2024 | View on chart |
| NPO | ▲ Buy | Grant | 942 | $110K | 2/16/2023 | View on chart |
| NPO | ▲ Buy | Grant | 1,041 | $110K | 2/15/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 7, 2026
NPO highlighted in recent stock comparison articles
Recent articles from ChartMill and Yahoo Finance have featured Enpro Inc. (NPO) in discussions about cash-producing stocks and value comparisons. These pieces analyze the company's financial metrics, such as return on invested capital and cash conversion, alongside its peer YMM. The coverage positions NPO as a subject of interest for investors evaluating quality and growth factors in the current market.
NPO highlighted in recent stock comparison articles. Recent articles from ChartMill and Yahoo Finance have featured Enpro Inc. (NPO) in discussions about cash-producing stocks and value comparisons. These pieces analyze the company's financial metrics, such as return on invested capital and cash conversion, alongside its peer YMM. The coverage positions NPO as a subject of interest for investors evaluating quality and growth factors in the current market.